These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12800452)

  • 41. [New combination therapy. Up to 60% lower LDL cholesterol level].
    MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
    [No Abstract]   [Full Text] [Related]  

  • 42. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 43. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
    Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plant sterols and their role in combined use with statins for lipid lowering.
    Normén L; Holmes D; Frohlich J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):307-16. PubMed ID: 15816508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania PC;
    Am Heart J; 2004 Dec; 148(6):1053-9. PubMed ID: 15632893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cholesterol: blood levels or total risk as a guide to preventive treatment?].
    Mathes P
    Z Kardiol; 2004; 93 Suppl 2():II16-20. PubMed ID: 15021991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing the risk of coronary heart disease via lipid reduction.
    Spratt KA
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 52. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
    MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
    [No Abstract]   [Full Text] [Related]  

  • 53. Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease.
    König D; Deibert P; Winkler K; Berg A
    Exerc Immunol Rev; 2005; 11():97-107. PubMed ID: 16385847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 57. Lowering of LDL cholesterol.
    Sniderman AD
    Lancet; 2000 Jan; 355(9199):235. PubMed ID: 10675147
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence supporting cholesterol-lowering therapy for postmenopausal women with heart disease.
    Goldstein MR
    JAMA; 1997 Aug; 278(8):633-4. PubMed ID: 9272889
    [No Abstract]   [Full Text] [Related]  

  • 59. Treating isolated low high-density lipoprotein cholesterol: prescient or premature?
    Harper CR; Jacobson TA
    Am J Cardiol; 2000 Feb; 85(4):484-6. PubMed ID: 10728955
    [No Abstract]   [Full Text] [Related]  

  • 60. Lowering of LDL cholesterol.
    Payne N; McCabe C
    Lancet; 1999 Oct; 354(9185):1207-8. PubMed ID: 10513735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.